Prospective non-interventional cohort study to assess safety and tolerability of 3Fluart 2021/2022 trivalent seasonal influenza vaccine in children, adolescents, adults and elderly subjects (3Fluart-H-30)

First published 19/05/2021

Last updated 17/04/2024

EU PAS number:

EUPAS41178

Study

Finalised

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Prospective non-interventional cohort study to assess safety and tolerability of 3Fluart 2021/2022 trivalent seasonal influenza vaccine in children, adolescents, adults and elderly subjects (3Fluart-H-30)

Secondary tabs

Share this page